Olema Pharmaceuticals, Inc. (OLMA)
25.07
-0.57
(-2.22%)
USD |
NASDAQ |
Dec 30, 16:00
25.13
+0.06
(+0.24%)
After-Hours: 20:00
Olema Pharmaceuticals EPS Diluted (Quarterly): -0.4924 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Cidara Therapeutics, Inc. | -3.096 |
| Cogent Biosciences, Inc. | -0.5884 |
| Replimune Group, Inc. | -0.9041 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.22M |
| Total Expenses (Quarterly) | 42.22M |
| Enterprise Value | 1.397B |
| Earnings Yield | -7.23% |
| Normalized Earnings Yield | -7.227 |